To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Voglibose (INN and USAN) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. It is made in India by Ranbaxy Labs and sold under the trade name Volix.
Additional recommended knowledge
glenmark is also producing voglibose under brand name vocarb.
Diabetes is chronic metabolic disorder characterised by hyperglycemia which is due to relative or absolute deficiency of insulin or insulin resistance.
PPHG is termed as Post Prandial Hyperglycemia which is primarily due to first phase insulin secretion. Alpha glucosidase inhibitor is one agent which delays the glucose absorption at the intestine level and thereby prevents sudden surge of glucose post meal.
There are three molecules which belong to this class namely, Acarbose, Miglitol and Voglibose. Voglibose is the latest molecule in this class. Voglibose scores over both Acarbose and MIglitol in terms of potenty and side effect profile.
There are several trials supporting the use of Voglibose in the management of PPHG. Also, it has been established that it is PPHG not FPG which is marker of cardiovascular disorders associeted with diabetes. So, controlling PPHG is imperative and Voglibose is indicated for the management of PPHG.
Sun Pharmaceuticals launched Voglibose 0.2 / 0.3 mg under the brand name VOLIBO.
For any further enquiry, pls write to email@example.com
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Voglibose". A list of authors is available in Wikipedia.|